Display options
Share it on

Case Reports Immunol. 2015;2015:816424. doi: 10.1155/2015/816424. Epub 2015 Mar 01.

Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.

Case reports in immunology

Teresa Urraro, Laura Gragnani, Alessia Piluso, Alessio Fabbrizzi, Monica Monti, Elisa Fognani, Barbara Boldrini, Jessica Ranieri, Anna Linda Zignego

Affiliations

  1. Center for Systemic Manifestations of Hepatitis Viruses (MASVE), Department of Experimental and Clinical Medicine, University of Florence, Lagro Brambilla 3, 50134 Florence, Italy.

PMID: 25815218 PMCID: PMC4359800 DOI: 10.1155/2015/816424

Abstract

Mixed cryoglobulinemia (MC) is an autoimmune/B-cell lymphoproliferative disorder associated with Hepatitis C Virus (HCV) infection, manifesting as a systemic vasculitis. In the last decade, antiviral treatment (AT) with pegylated interferon (Peg-IFN) plus ribavirin (RBV) was considered the first therapeutic option for HCV-MC. In MC patients ineligible or not responsive to antivirals, the anti-CD20 monoclonal antibody rituximab (RTX) is effective. A combined AT plus RTX was also suggested. Since the introduction of direct acting antivirals (DAAs), few data were published about MC and no data about a combined schedule. Here, we report a complete remission of MC after a sustained virological response following a combined RTX/Peg-IFN+RBV+DAA (boceprevir) treatment and review the literature about the combined RTX/AT.

References

  1. Blood. 2003 May 15;101(10):3827-34 - PubMed
  2. Blood Transfus. 2012 Jan;10(1):101-3 - PubMed
  3. J Hepatol. 2011 Aug;55(2):245-64 - PubMed
  4. Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S165-73 - PubMed
  5. Ann Rheum Dis. 2014 Sep;73(9):e58 - PubMed
  6. Ann Rheum Dis. 2014 May;73(5):831-7 - PubMed
  7. Expert Rev Clin Immunol. 2015 Jan;11(1):15-31 - PubMed
  8. Clin Dev Immunol. 2012;2012:980942 - PubMed
  9. Blood. 1993 Mar 1;81(5):1132-6 - PubMed
  10. Hepatology. 2015 Apr;61(4):1145-53 - PubMed
  11. J Viral Hepat. 2013 Apr;20(4):e107-14 - PubMed
  12. Haematologica. 1999 Dec;84(12):1157-8 - PubMed
  13. Arthritis Rheum. 2009 Aug;60(8):2531-40 - PubMed
  14. Intern Emerg Med. 2012 Oct;7 Suppl 3:S201-8 - PubMed
  15. Antivir Ther. 2014;19(5):527-31 - PubMed
  16. N Engl J Med. 1994 Mar 17;330(11):751-6 - PubMed
  17. J Hepatol. 2015 Jan;62(1):24-30 - PubMed
  18. Autoimmun Rev. 2011 Nov;11(1):48-55 - PubMed
  19. Ann Rheum Dis. 2014 Sep;73(9):e59 - PubMed
  20. Ann Rheum Dis. 2011 Jul;70(7):1183-90 - PubMed
  21. Blood. 2010 Jul 22;116(3):326-34; quiz 504-5 - PubMed
  22. N Engl J Med. 2011 Mar 31;364(13):1195-206 - PubMed
  23. Am J Med. 1987 Oct;83(4):726-30 - PubMed
  24. Dig Liver Dis. 2014 Sep;46(9):833-7 - PubMed
  25. N Engl J Med. 2011 Jun 23;364(25):2405-16 - PubMed
  26. Blood. 2003 May 15;101(10):3818-26 - PubMed
  27. Ann Rheum Dis. 2008 Oct;67(10 ):1431-6 - PubMed
  28. Med Oncol. 1995 Dec;12 (4):223-30 - PubMed
  29. Autoimmun Rev. 2011 Jun;10 (8):444-54 - PubMed
  30. Blood. 2010 Jul 22;116(3):343-53 - PubMed
  31. Arthritis Rheum. 2012 Mar;64(3):843-53 - PubMed
  32. Blood. 2010 Jul 22;116(3):335-42 - PubMed

Publication Types